Differential Diagnosis for Low Albumin, Low Protein, and Low Alkaline Phosphatase

Introduction to Differential Diagnosis

The American Association for the Study of Liver Diseases recommends that the combination of low albumin, low total protein, and low alkaline phosphatase should immediately raise suspicion for Wilson disease presenting as fulminant hepatic failure, particularly if accompanied by hemolytic anemia, though other causes including severe malnutrition, chronic kidney disease with protein losses, and advanced liver disease must be systematically excluded 1

The American Association for the Study of Liver Diseases suggests that Wilson disease must be ruled out urgently when low alkaline phosphatase (<40 IU/L) occurs with hypoalbuminemia, especially in patients under 40 years old 1, 2
The characteristic pattern of Wilson disease includes markedly subnormal alkaline phosphatase (typically <40 IU/L) 1, 2
Coombs-negative hemolytic anemia with acute intravascular hemolysis is a characteristic feature of Wilson disease 1
Modest aminotransferase elevations (typically <2,000 IU/L) are commonly seen in Wilson disease 1
Alkaline phosphatase to total bilirubin ratio <2 is characteristic of Wilson disease 1, 2
Coagulopathy unresponsive to parenteral vitamin K is a feature of Wilson disease 1
Female predominance (2:1 ratio) is observed in Wilson disease 1

Inflammation is the most common cause of low albumin in hospitalized patients and should be the first consideration in most clinical contexts, according to the American College of Physicians 3
Inflammatory cytokines (TNF-α, IL-6) directly downregulate hepatic albumin synthesis, as stated by the National Kidney Foundation 4, 3
C-reactive protein inversely correlates with serum albumin regardless of dietary protein intake, as reported by the National Kidney Foundation 4, 3
Low albumin loses predictive power for mortality when CRP is included in multivariate analysis, according to the National Kidney Foundation 4

Approximately one-third of chronic kidney disease patients have low albumin, making this a high-probability diagnosis, as stated by the National Kidney Foundation 3
External protein losses through urine (nephrotic syndrome) or dialysate (peritoneal dialysis) are common in chronic kidney disease, according to the National Kidney Foundation 4, 6, 3
Fluid overload causing dilutional hypoalbuminemia is a feature of chronic kidney disease, as reported by the National Kidney Foundation 4, 6
Comorbid conditions (diabetes, cardiovascular disease) are strongly associated with low albumin in chronic kidney disease, according to the National Kidney Foundation 4, 7
Age is an independent predictor of low albumin in dialysis patients, as stated by the National Kidney Foundation 4

Severe end-stage liver disease of any etiology impairs hepatic albumin synthesis, as reported by the American Association for the Study of Liver Diseases 3

True malnutrition should be diagnosed through dietary assessment and normalized protein nitrogen appearance (nPNA), not albumin alone, according to the National Kidney Foundation 4, 7, 3
Dietary protein intake <1.2-1.3 g/kg/day in stable patients is indicative of malnutrition, as stated by the National Kidney Foundation 7
nPNA <0.9 g/kg/day is indicative of malnutrition, according to the National Kidney Foundation 7
Declining albumin (>0.1 g/dL/month) from baseline is a feature of malnutrition, as reported by the National Kidney Foundation 7
Absence of inflammatory markers or external protein losses is necessary for the diagnosis of malnutrition, according to the American College of Physicians 3

Protein-losing enteropathy and inflammatory bowel disease with malabsorption cause hypoproteinemia through direct GI losses, as stated by the European Association for the Study of the Liver 8, 3

Antiresorptive medications (bisphosphonates) lower alkaline phosphatase levels, which may cause relative elevation of pyridoxal phosphate due to reduced enzymatic degradation, according to the American College of Rheumatology 2

Immediate assessment for Wilson disease if age <40 years: Check hemolysis markers, ceruloplasmin, urinary copper, slit-lamp exam, calculate ALP/bilirubin ratio, as recommended by the American Association for the Study of Liver Diseases 1, 2
Measure inflammatory markers: CRP, ESR to identify inflammation as primary driver, according to the American College of Physicians 3
Quantify protein losses: 24-hour urine protein, assess volume status, consider stool studies, as stated by the National Kidney Foundation 3
Assess nutritional intake: Dietary interview, calculate nPNA if applicable, according to the National Kidney Foundation 7, 3
Evaluate liver synthetic function: PT/INR, bilirubin, consider imaging for chronic liver disease, as reported by the European Association for the Study of the Liver 8
Review medications: Identify drugs affecting ALP or causing malabsorption, according to the American College of Rheumatology 2